Bud Dupree

Edge Rusher

Age: 31
Free Agency: 2024 (UFA)
Accrued Seasons: 9
  • 2024 Salary Cap Charge: $0 (0.00% of cap)
  • 2024 Cash Payout: $0 (0.00% of spending)
  • 2024 Cash to Cap Ratio: 0
  • Contract Value: $3,000,000 ($3,000,000 APY)
  • Fully Guaranteed Money: $2,490,000
  • Contract Ranking: 61/232 at EDGE

Current Contract

(SFA, signed 2023)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202330$1,240,000$1,250,000$510,000$1,240,000$2,970,0001.3%
Total$1,240,000$1,250,000$510,000$1,240,000$2,970,000

Contract Notes

Bud Dupree signed a one year, $3 million contract with the Falcons. $2.49 million of the contract is guaranteed including a $1.25 million signing bonus.

Cash Flows

- old money
- fully earned money
- unearned or partially earned money
$3M
Old Money2023
Cash Due$30,000$2,970,000
Running Cash$3,000,000
Career Earnings: $72,428,757
Career APY: $8,047,640
Potential Earnings: $71,178,757
Total Guarantees: $60,700,701
Largest Cash Payment: $17,926,471 (2021)
Largest Cap Number: $19,200,000 (2022)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
SteelersDraftedExpired20154$18,454,286$3,690,598$8,632,701$18,454,286100.0%$3,690,857
SteelersFranchiseExpired20201$15,828,000$15,828,000$15,828,000$15,828,000100.0%$15,828,000
TitansUFATerminated20215$82,500,000$16,500,000$33,750,000$33,926,47141.1%$16,963,236
FalconsSFAActive20231$3,000,000$3,000,000$2,490,000$2,970,00099.0%$2,970,000
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Steelers6$34,282,286$5,713,714$34,282,2860.0%$00.0%
Titans2$35,176,471$17,588,236$24,326,4710.0%$10,850,0000.0%
Falcons1$2,970,000$2,970,000$2,970,0000.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2015Steelers$435,000$1,241,779$0$435,000$1,676,7791.2%$5,402,116
2016Steelers$854,195$1,241,779$0$854,195$2,095,9741.3%$854,195
2017Steelers$1,273,390$1,241,779$0$1,273,390$2,515,1691.5%$1,273,390
2018Steelers$1,692,585$1,241,779$0$1,103,000$2,934,3641.6%$1,692,585
2019Steelers$9,232,000$0$0$9,232,000$9,232,0004.5%$9,232,000
2020Steelers$15,828,000$0$0$15,828,000$15,828,0007.9%$15,828,000
2021Titans$1,750,000$3,200,000$250,000$1,750,000$5,126,4712.7%$17,926,471
2022Titans$16,000,000$3,200,000$0$16,000,000$19,200,0009.1%$16,000,000
2023Falcons$1,240,000$1,250,000$510,000$1,240,000$2,970,0001.3%$2,970,000
Total$48,305,170$12,617,116$760,000$47,715,585$61,578,757$71,178,757
Dead Money History
TeamYearCap ChargeCash Paid
Titans2023$10,850,000$1,250,000
Total$10,850,000$1,250,000

Statistics

YearGames PlayedGames InactiveSnapsTacklesNegative PlaysInterceptionsFumblesTD
InjuredHealthyDefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
2015160050.6%21.3%17947461000000
201679030.4%2.7%1954.524561001000
2017151081.2%10.8%3196561271000100
2018160083.2%13.3%30125.539.581331101001
2019160090.6%14.9%491911.55716163004200
2020110059.1%7.1%2388468152002000
2021112036.2%3.7%134323281001000
2022113138.8%0.0%144424690001200
2023161063.6%0.9%17226.528.5883002000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$6,420,000$3,000,000
Injury Adjusted$7,012,113$2,812,500
test
OTC Valuation $5.9M $11.7M $17.6M $23.5M $29.4M APY $5.7M $11.3M $17M $22.7M $28.3M $11,201,000 $8,803,205

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.